title: Making diagnosis of Pompe disease at a presymptomatic stage: to treat or not to treat?
authors.affiliation: Institut de Myologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
authors.forename: K
authors.initials: K
authors.lastname: Laloui
authors.forename: C
authors.initials: C
authors.lastname: Wary
authors.forename: R-Y
authors.initials: RY
authors.lastname: Carlier
authors.forename: J-Y
authors.initials: JY
authors.lastname: Hogrel
authors.forename: C
authors.initials: C
authors.lastname: Caillaud
authors.forename: P
authors.initials: P
authors.lastname: Laforêt
mesh_terms: D000375:Aging / Q000473:pathology; D001706:Biopsy; D018450:Disease Progression; D042241:Early Diagnosis; D056947:Enzyme Replacement Therapy; D006003:Glycogen / Q000378:metabolism; D006009:Glycogen Storage Disease Type II / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D053580:Muscle Strength / Q000502:physiology; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology; D055815:Young Adult; D000520:alpha-Glucosidases / Q000627:therapeutic use*
chemical_list: D006003:Glycogen; D000520:alpha-Glucosidases